Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 140th ranked industry out of 146 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
DTIL	PRECISION BIOSCIENCES INC	$188.10M	-79.60%	-34.80%	-31.01%	-113.80%	0.89	14.02	100.00%	-96.70%	-93.67%
CDXS	CODEXIS INC	$217.24M	-68.10%	-23.70%	-23.36%	-18.10%	1.99	5.36	88.90%	-41.00%	-34.26%
GMAB	GENMAB A	$16.78B	14.50%	8.50%	12.60%	34.20%	1.18	2.18	93.30%	21.00%	36.17%
LEGN	LEGEND BIOTECH CORP	$5.33B	-24.90%	-14.90%	-19.75%	-31.30%	0.65	2.13	55.00%	-22.00%	-18.86%
LIXT	LIXTE BIOTECHNOLOGY HOLDINGS INC	$89.03M	-126.20%	-96.80%	-74.84%	-174.20%	0.21	2.78	N/A	N/A	N/A
RAPP	RAPPORT THERAPEUTICS INC	$1.92B	-24.80%	-23.40%	-22.36%	-31.20%	0.06	27.08	100.00%	-536.40%	-536.39%
DARE	DARE BIOSCIENCE INC	$31.31M	N/A	-46.20%	-179.16%	113.60%	36.89	1.03	53.50%	-1,038.80%	-1,038.77%
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	$119.14M	N/A	-1,168.70%	273.68%	323.40%	-1.25	0.13	N/A	N/A	N/A
AXSM	AXSOME THERAPEUTICS INC	$12.44B	-260.00%	-27.80%	-66.88%	-125.30%	12.07	1.39	92.60%	-26.60%	-25.91%
CCCC	C4 THERAPEUTICS INC	$471.02M	-50.70%	-33.20%	-34.38%	-38.90%	0.40	9.01	100.00%	-297.80%	-297.41%
IOVA	IOVANCE BIOTHERAPEUTICS INC	$1.90B	-50.20%	-38.80%	-44.55%	-92.90%	0.28	3.61	36.70%	-123.90%	-124.21%
PBLS	PARABILIS MEDICINES INC	N/A	N/A	N/A	N/A	N/A	-0.25	6.12	N/A	N/A	N/A
ANTX	AN2 THERAPEUTICS INC	$187.28M	-52.30%	-47.30%	-42.17%	-89.30%	0.07	15.73	N/A	N/A	N/A
HYFT	MINDWALK HOLDINGS CORP	$73.80M	-63.70%	-36.50%	-67.58%	-72.80%	0.55	3.74	60.30%	-66.50%	-65.87%
PLYX	POLARYX THERAPEUTICS INC	$113.62M	N/A	N/A	N/A	N/A	0.41	3.45	N/A	N/A	N/A
SNDX	SYNDAX PHARMACEUTICALS INC	$1.89B	-256.70%	-45.20%	-53.21%	-31.60%	10.36	5.47	96.00%	-111.90%	-94.59%
ZYME	ZYMEWORKS INC	$1.76B	-37.80%	-25.20%	-23.03%	-31.60%	1.92	10.82	100.00%	-126.30%	-125.40%
QNCX	QUINCE THERAPEUTICS INC	$15.39M	N/A	-38.10%	-197.19%	-215.70%	0.70	2.92	N/A	N/A	N/A
NVCT	NUVECTIS PHARMA INC	$721.23M	-161.00%	-98.90%	-191.00%	238.90%	0.79	2.27	N/A	N/A	N/A
QURE	UNIQURE NV	$3.00B	-145.80%	-27.20%	-19.78%	-16.30%	4.21	10.40	90.60%	-1,154.40%	-786.66%
LGND	LIGAND PHARMACEUTICALS INC	$6.08B	16.20%	11.10%	12.77%	15.60%	0.54	21.28	95.30%	55.90%	69.40%
ABVX	ABIVAX SA	$7.70B	-98.60%	-69.80%	-44.05%	-1,055.50%	0.27	8.25	100.00%	-6,752.00%	-4,341.95%
RIGL	RIGEL PHARMACEUTICALS INC	$715.85M	147.00%	99.30%	31.05%	49.00%	0.26	2.62	93.40%	121.50%	42.99%
MAZE	MAZE THERAPEUTICS INC	$1.57B	-36.60%	-31.80%	-30.54%	-78.90%	0.23	17.88	100.00%	-612.70%	-608.38%
PTHS	PELTHOS THERAPEUTICS INC	$100.90M	-164.10%	-51.20%	-44.65%	-135.60%	3.14	2.79	79.60%	-186.20%	-194.02%
CYTK	CYTOKINETICS INC	$10.23B	N/A	-61.90%	-72.46%	-35.50%	-2.54	4.21	97.60%	-784.00%	-735.60%
WVE	WAVE LIFE SCIENCES LTD	$1.12B	-56.80%	-42.80%	-34.40%	931.70%	0.14	11.26	100.00%	-255.70%	-255.70%
ELVN	ENLIVEN THERAPEUTICS INC	$3.05B	-21.00%	-20.40%	-21.79%	-27.70%	0.03	40.32	N/A	N/A	N/A
ACAD	ACADIA PHARMACEUTICALS INC	$4.34B	35.60%	26.20%	8.86%	14.50%	0.29	3.59	91.50%	34.30%	10.51%
SRZN	SURROZEN INC	$292.81M	N/A	-346.50%	-324.35%	-3,450.40%	-1.43	11.91	100.00%	-4,810.50%	-4,810.50%
BEAM	BEAM THERAPEUTICS INC	$3.58B	-5.90%	-4.60%	-4.63%	-5.60%	0.27	16.99	100.00%	-39.70%	-39.66%
LTRN	LANTERN PHARMA INC	$43.64M	-198.30%	-129.10%	-461.79%	-732.60%	1.10	1.87	N/A	N/A	N/A
JAGX	JAGUAR HEALTH INC	$1.82M	N/A	-115.60%	1,023.95%	-172.70%	-3.75	0.50	85.10%	-169.50%	-112.61%
FATE	FATE THERAPEUTICS INC	$244.77M	-58.90%	-39.40%	-51.10%	-39.90%	0.59	5.85	100.00%	-2,056.80%	-2,056.79%
CNXU	CONEXEU SCIENCES INC	$293.27M	N/A	N/A	N/A	N/A	0.14	7.89	N/A	N/A	N/A
ACET	ADICET BIO INC	$78.24M	-80.40%	-65.40%	-72.00%	-87.30%	0.21	7.66	N/A	N/A	N/A
ENLV	ENLIVEX LTD	$135.31M	248.10%	206.40%	69.81%	279.90%	0.20	193.24	N/A	N/A	N/A
MGTX	MEIRAGTX HOLDINGS PLC	$1.12B	N/A	-55.00%	-158.37%	-83.30%	-5.21	0.55	95.40%	-151.10%	-136.08%
HYPD	HYPERION DEFI INC	$46.38M	-68.40%	-54.50%	-41.16%	-44.30%	0.20	1.97	70.90%	-3,402.70%	-2,588.52%
MESO	MESOBLAST LTD	$1.70B	-18.20%	-13.10%	-10.17%	-72.20%	0.36	1.58	80.50%	-144.30%	-101.79%
SDEV	STABLECOIN DEVELOPMENT CORP	$30.10M	-284.40%	-172.80%	-46.88%	-206.10%	0.30	5.33	N/A	N/A	N/A
RYTM	RHYTHM PHARMACEUTICALS INC	$7.53B	-208.40%	-46.10%	-53.66%	-69.50%	1.67	4.17	89.40%	-95.70%	-83.79%
CHRS	COHERUS ONCOLOGY INC	$231.37M	214.60%	50.30%	146.09%	9,214.60%	2.38	1.56	68.10%	397.30%	416.58%
CORT	CORCEPT THERAPEUTICS INC	$9.37B	7.30%	5.70%	-1.34%	-1.60%	0.28	2.86	98.30%	6.10%	-1.16%
ACHV	ACHIEVE LIFE SCIENCES INC	$618.01M	-193.50%	-111.90%	-240.13%	-362.20%	2.10	2.63	N/A	N/A	N/A
SLGL	SOL-GEL TECHNOLOGIES LTD	$240.27M	-3.20%	-2.60%	-2.00%	-4.00%	0.14	8.84	100.00%	-5.70%	-5.70%
PHAT	PHATHOM PHARMACEUTICALS INC	$854.98M	N/A	-59.70%	-50.79%	-16.70%	-1.91	2.21	84.90%	-76.80%	-44.64%
ALXO	ALX ONCOLOGY HOLDINGS INC	$274.51M	-124.10%	-85.60%	-55.23%	-128.90%	0.18	7.21	N/A	N/A	N/A
RNA	ATRIUM THERAPEUTICS INC	$225.62M	N/A	N/A	N/A	N/A	0.25	13.04	N/A	N/A	N/A
PBM	PSYENCE BIOMEDICAL LTD	$6.81M	-58.60%	-55.80%	-40.88%	-138.50%	0.04	14.62	N/A	N/A	N/A
SPTX	SEAPORT THERAPEUTICS INC	$1.15B	N/A	N/A	N/A	N/A	-0.16	13.24	N/A	N/A	N/A
GALT	GALECTIN THERAPEUTICS INC	$328.63M	N/A	-165.90%	-220.99%	-21.00%	-1.11	2.15	N/A	N/A	N/A
LXEO	LEXEO THERAPEUTICS INC	$372.98M	-47.50%	-41.70%	-37.01%	-61.60%	0.08	14.16	N/A	N/A	N/A
ALDX	ALDEYRA THERAPEUTICS INC	$110.39M	-57.30%	-36.30%	-60.44%	-576.70%	0.58	2.72	N/A	N/A	N/A
INKT	MINK THERAPEUTICS INC	$57.99M	N/A	-118.60%	-403.62%	182.80%	-1.82	1.38	N/A	N/A	N/A
PDSB	PDS BIOTECHNOLOGY CORP	$49.56M	-346.00%	-102.40%	-199.49%	-237.90%	5.34	2.26	N/A	N/A	N/A
LONA	LEONABIO INC	$88.30M	-381.00%	-225.70%	-199.33%	-1,888.60%	0.45	10.38	N/A	N/A	N/A
BLTE	BELITE BIO INC	$5.85B	-16.90%	-16.60%	-10.07%	-29.10%	0.01	50.02	N/A	N/A	N/A
CLYM	CLIMB BIO INC	$748.97M	-31.50%	-30.40%	-35.60%	-36.30%	0.03	27.86	N/A	N/A	N/A
MDGL	MADRIGAL PHARMACEUTICALS INC	$11.82B	-50.20%	-25.40%	-31.79%	-29.40%	1.26	3.50	93.10%	-27.30%	-24.95%
AVLN	AVALYN PHARMA INC	$1.36B	N/A	N/A	N/A	N/A	-0.11	11.03	N/A	N/A	N/A
DNTH	DIANTHUS THERAPEUTICS INC	$5.21B	-27.30%	-25.90%	-14.37%	-38.00%	0.04	29.25	100.00%	-12,998.50%	-12,998.50%
DOMH	DOMINARI HOLDINGS INC	$66.26M	-47.50%	-35.60%	N/A	-24.50%	1.70	N/A	100.00%	-31.40%	-17.98%
NVAX	NOVAVAX INC	$1.46B	N/A	-7.40%	-9.20%	-9.70%	-8.21	2.48	85.00%	-14.70%	-10.81%
MANE	VERADERMICS INC	$5.30B	N/A	N/A	N/A	N/A	0.02	59.12	N/A	N/A	N/A
ACXP	ACURX PHARMACEUTICALS INC	$6.53M	-153.90%	-101.70%	-106.92%	322.60%	0.36	3.78	N/A	N/A	N/A
ALGS	ALIGOS THERAPEUTICS INC	$34.47M	-139.50%	-90.90%	-226.95%	-167.20%	1.03	2.56	100.00%	-1,919.70%	-1,989.08%
GRDX	GRIDAI TECHNOLOGIES CORP	$29.34M	-63.50%	-11.00%	-26.43%	-39.90%	1.10	0.16	-1,707.20%	-11,664.80%	-11,263.67%
ALLO	ALLOGENE THERAPEUTICS INC	$735.18M	-56.40%	-40.40%	-46.93%	-49.80%	0.42	9.65	N/A	N/A	N/A
AGMB	AGOMAB THERAPEUTICS NV	$673.05M	-39.20%	-34.70%	-46.19%	-629.60%	0.17	6.52	N/A	N/A	N/A
LKFT	LAKEFRONT BIOTHERAPEUTICS NV	$1.94B	16.90%	13.90%	14.43%	15.00%	0.04	30.48	97.90%	49.70%	47.97%
CLRB	CELLECTAR BIOSCIENCES INC	$20.14M	-321.20%	-153.20%	-333.67%	1,004.80%	1.92	1.90	N/A	N/A	N/A
RLMD	RELMADA THERAPEUTICS INC	$701.72M	-71.20%	-64.50%	-26.47%	-73.70%	0.08	18.26	N/A	N/A	N/A
ATRA	ATARA BIOTHERAPEUTICS INC	$94.70M	N/A	-35.30%	-40.63%	-10.20%	-1.54	2.16	96.10%	-40.90%	-25.20%
ATAI	ATAIBECKLEY INC	$1.95B	-366.50%	-269.00%	-276.34%	-390.80%	0.33	10.02	100.00%	-19,019.40%	-19,007.28%
XFOR	X4 PHARMACEUTICALS INC	$379.17M	-94.90%	-48.10%	-36.88%	-92.30%	0.61	10.18	81.80%	-1,106.30%	-1,008.50%
NAUT	NAUTILUS BIOTECHNOLOGY INC	$254.16M	-35.00%	-29.20%	-33.69%	-29.30%	0.23	11.85	N/A	N/A	N/A
KURA	KURA ONCOLOGY INC	$967.64M	-142.00%	-43.30%	-53.18%	-58.80%	5.05	6.15	99.60%	-411.20%	-409.03%
CGEM	CULLINAN THERAPEUTICS INC	$1.13B	-51.80%	-47.90%	-60.09%	-63.60%	0.10	10.28	N/A	N/A	N/A
RNTX	REIN THERAPEUTICS INC	$83.06M	-163.70%	-124.30%	-402.50%	976.80%	1.27	0.40	N/A	N/A	N/A
OKUR	ONKURE THERAPEUTICS INC	$181.78M	-61.00%	-56.00%	-31.86%	1,401.00%	0.08	13.78	N/A	N/A	N/A
NNVC	NANOVIRICIDES INC	$29.01M	-92.70%	-81.60%	-88.39%	-143.20%	0.12	3.17	N/A	N/A	N/A
CAMP	CAMP4 THERAPEUTICS CORP	$218.09M	-194.70%	-95.60%	-97.15%	-12,049.00%	2.41	6.15	100.00%	-2,193.70%	-2,193.72%
SGMT	SAGIMET BIOSCIENCES INC	$431.96M	-37.60%	-35.50%	-42.47%	-54.90%	0.05	20.34	N/A	N/A	N/A
COAG	HEMAB THERAPEUTICS HOLDINGS INC	$1.51B	N/A	N/A	N/A	N/A	-0.07	12.85	N/A	N/A	N/A
CGTX	COGNITION THERAPEUTICS INC	$100.24M	-72.70%	-53.10%	-65.02%	811.40%	0.21	5.92	N/A	N/A	N/A
IDYA	IDEAYA BIOSCIENCES INC	$3.23B	-14.00%	-12.80%	-14.51%	-15.80%	0.10	10.74	100.00%	-62.20%	-62.17%
ARMP	ARMATA PHARMACEUTICALS INC	$271.66M	N/A	-356.60%	-435.96%	-110.60%	-1.22	0.64	N/A	N/A	N/A
PLRX	PLIANT THERAPEUTICS INC	$70.59M	-59.10%	-45.10%	-57.98%	-51.60%	0.23	16.89	N/A	N/A	N/A
BBIO	BRIDGEBIO PHARMA INC	$13.76B	N/A	-65.80%	-116.69%	-32.30%	-1.60	1.52	95.10%	-124.40%	-111.59%
AKTS	AKTIS ONCOLOGY INC	$1.57B	N/A	N/A	N/A	N/A	0.14	19.49	N/A	N/A	N/A
DBVT	DBV TECHNOLOGIES SA	$947.93M	-129.90%	-88.80%	-77.72%	2,867.80%	0.28	4.76	100.00%	-2,895.40%	-2,883.42%
OTLK	OUTLOOK THERAPEUTICS INC	$206.68M	N/A	-300.60%	366.05%	-2,177.20%	-1.76	0.54	-360.90%	-18,297.50%	-18,670.06%
PEPG	PEPGEN INC	$117.59M	-59.90%	-49.60%	-52.37%	-87.20%	0.17	14.98	N/A	N/A	N/A
IBRX	IMMUNITYBIO INC	$9.12B	N/A	-165.20%	-128.27%	-60.00%	-1.74	6.67	99.30%	-606.20%	-526.54%
DSGN	DESIGN THERAPEUTICS INC	$833.80M	-33.10%	-31.30%	-31.65%	-35.40%	0.06	22.28	N/A	N/A	N/A
CRBU	CARIBOU BIOSCIENCES INC	$166.62M	-100.10%	-72.00%	-103.44%	-78.30%	0.46	6.22	100.00%	-1,512.80%	-1,519.07%
ABSI	ABSCI CORP	$1.70B	-63.60%	-54.70%	-67.32%	-92.70%	0.14	6.59	100.00%	-6,450.80%	-6,437.75%
ARWR	ARROWHEAD PHARMACEUTICALS INC	$11.11B	-55.40%	-18.10%	-9.57%	-9.10%	2.72	6.23	100.00%	-48.40%	-30.37%
PHVS	PHARVARIS NV	$2.22B	-67.10%	-60.70%	N/A	-1,487.80%	0.10	N/A	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jun 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #1 top biotech stock out of 608 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 34, which is 10 points higher than the biotech industry average of 24.

JAZZ passed 11 out of 33 due diligence checks and has average fundamentals. Jazz Pharmaceuticals has seen its stock return 113.95% over the past year, overperforming other biotech stocks by 186 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $259.25, an upside of 12.71% from Jazz Pharmaceuticals's current stock price of $230.02.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Jazz Pharmaceuticals, 66.67% have issued a Strong Buy rating, 25% have issued a Buy, 8.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Immucell (NASDAQ:ICCC)

Immucell (NASDAQ:ICCC) is the #2 top biotech stock out of 608 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Immucell (NASDAQ:ICCC) is: Value: C, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: B.

Immucell (NASDAQ:ICCC) has a Due Diligence Score of 19, which is -5 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates ICCC as a "A".

ICCC passed 6 out of 33 due diligence checks and has weak fundamentals. Immucell has seen its stock return 44.18% over the past year, overperforming other biotech stocks by 116 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the #3 top biotech stock out of 608 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Exelixis (NASDAQ:EXEL) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: B.

Exelixis (NASDAQ:EXEL) has a Due Diligence Score of 45, which is 21 points higher than the biotech industry average of 24.

EXEL passed 15 out of 33 due diligence checks and has strong fundamentals. Exelixis has seen its stock return 27.11% over the past year, overperforming other biotech stocks by 99 percentage points.

Exelixis has an average 1 year price target of $49.44, a downside of -9.72% from Exelixis's current stock price of $54.77.

Exelixis stock has a consensus Buy recommendation according to Wall Street analysts. Of the 9 analysts covering Exelixis, 11.11% have issued a Strong Buy rating, 22.22% have issued a Buy, 66.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Centessa Pharmaceuticals (NASDAQ:CNTA)

Centessa Pharmaceuticals (NASDAQ:CNTA) has an annual dividend yield of 93.83%, which is 77 percentage points higher than the biotech industry average of 17.22%.

Centessa Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 33.28%, which is 16 percentage points higher than the biotech industry average of 17.22%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 5.35%, which is -12 percentage points lower than the biotech industry average of 17.22%.

Oramed Pharmaceuticals's dividend payout ratio of 9.4% indicates that its high dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.86% in the last day, and up 4.5% over the last week. Hemab Therapeutics Holdings was the among the top gainers in the biotechnology industry, gaining 16.77% yesterday.

Hemab Therapeutics Holdings shares are trading higher after the company announced it will present clinical and preclinical data from multiple blood coagulation programs at ISTH 2026.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Cormedix (NASDAQ:CRMD)

Cormedix (NASDAQ:CRMD) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Cormedix has a valuation score of 43, which is 31 points higher than the biotech industry average of 12. It passed 3 out of 7 valuation due diligence checks.

Cormedix's stock has dropped -47.53% in the past year. It has overperformed other stocks in the biotech industry by 24 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 45 points higher than the biotech industry average of 12. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 11.33% in the past year. It has overperformed other stocks in the biotech industry by 83 percentage points.

3. Biomarin Pharmaceutical (NASDAQ:BMRN)

Biomarin Pharmaceutical (NASDAQ:BMRN) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Biomarin Pharmaceutical has a valuation score of 29, which is 17 points higher than the biotech industry average of 12. It passed 2 out of 7 valuation due diligence checks.

Biomarin Pharmaceutical's stock has gained 9.06% in the past year. It has overperformed other stocks in the biotech industry by 81 percentage points.

Are biotech stocks a good buy now?

68.48% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 52.71% over the next year.

2.59% of biotech stocks have a Zen Rating of A (Strong Buy), 3.88% of biotech stocks are rated B (Buy), 45.26% are rated C (Hold), 36.64% are rated D (Sell), and 11.64% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 16.11x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

2. Immucell (NASDAQ:ICCC)

3. Exelixis (NASDAQ:EXEL)

1. Centessa Pharmaceuticals (NASDAQ:CNTA)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Cormedix (NASDAQ:CRMD)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Biomarin Pharmaceutical (NASDAQ:BMRN)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

2. Immucell (NASDAQ:ICCC)

3. Exelixis (NASDAQ:EXEL)

1. Centessa Pharmaceuticals (NASDAQ:CNTA)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Cormedix (NASDAQ:CRMD)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Biomarin Pharmaceutical (NASDAQ:BMRN)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.